These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22552002)
1. Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors. Lee BA; Yu L; Ma L; Lind AC; Lu D J Am Acad Dermatol; 2012 Dec; 67(6):1228-34. PubMed ID: 22552002 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome. Ponti G; Longo C J Am Acad Dermatol; 2013 Mar; 68(3):509-10. PubMed ID: 23394915 [No Abstract] [Full Text] [Related]
3. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer. Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167 [TBL] [Abstract][Full Text] [Related]
4. Reply: To PMID 22552002. Lu D J Am Acad Dermatol; 2013 Mar; 68(3):510. PubMed ID: 23394916 [No Abstract] [Full Text] [Related]
5. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors]. Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166 [TBL] [Abstract][Full Text] [Related]
6. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Gaskin BJ; Fernando BS; Sullivan CA; Whitehead K; Sullivan TJ Br J Ophthalmol; 2011 Dec; 95(12):1686-90. PubMed ID: 21979897 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. Abbas O; Mahalingam M J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040 [TBL] [Abstract][Full Text] [Related]
8. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients. Joly MO; Attignon V; Saurin JC; Desseigne F; Leroux D; Martin-Denavit T; Giraud S; Bonnet-Dupeyron MN; Faivre L; Auclair J; Grand-Masson C; Audoynaud C; Wang Q Hum Mutat; 2015 Mar; 36(3):292-5. PubMed ID: 25504677 [TBL] [Abstract][Full Text] [Related]
9. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics. Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947 [TBL] [Abstract][Full Text] [Related]
11. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714 [TBL] [Abstract][Full Text] [Related]
12. Muir-Torre syndrome: a case report and review of the literature. Pettey AA; Walsh JS Cutis; 2005 Mar; 75(3):149-55. PubMed ID: 15839358 [TBL] [Abstract][Full Text] [Related]
13. Muir-Torre syndrome. Cohen PR; Kohn SR; Davis DA; Kurzrock R Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655 [TBL] [Abstract][Full Text] [Related]
14. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Ponti G; Ponz de Leon M; Maffei S; Pedroni M; Losi L; Di Gregorio C; Gismondi V; Scarselli A; Benatti P; Roncari B; Seidenari S; Pellacani G; Varotti C; Prete E; Varesco L; Roncucci L Clin Genet; 2005 Nov; 68(5):442-7. PubMed ID: 16207212 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population. Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614 [TBL] [Abstract][Full Text] [Related]
16. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076 [TBL] [Abstract][Full Text] [Related]
17. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy. Landis MN; Davis CL; Bellus GA; Wolverton SE J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in Muir-Torre syndrome. Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799 [TBL] [Abstract][Full Text] [Related]
20. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome. Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]